Biological aortic valve replacement: advantages and optimal indications of stentless compared to stented valve substitutes. A review
- PMID: 29322433
- DOI: 10.1007/s11748-018-0884-3
Biological aortic valve replacement: advantages and optimal indications of stentless compared to stented valve substitutes. A review
Abstract
Controversy still surrounds the optimal biological valve substitute for aortic valve replacement. In light of the current literature, we review advantages and optimal indications of stentless compared to stented aortic bio-prostheses. Recent meta-analyses, prospective randomized controlled trials and retrospective studies comparing the most frequently used stentless and stented aortic bio-prostheses were analyzed. In the present review, the types and implantation techniques of the bio-prosthesis that are seldom taken into account by most studies and reviews were integrated in the interpretation of the relevant reports. For stentless aortic root bio-prostheses, full-root vs. sub-coronary implantation offered better early transvalvular gradients, effective orifice area and left ventricular mass regression as well as late freedom from structural valve deterioration in retrospective studies. Early mortality and morbidity did not differ between the stentless and stented aortic bio-prostheses. Early transvalvular gradients, effective orifice area and regression of left ventricular hypertrophy were significantly better for stentless, especially as full-root, compared to stented bio-prostheses. The long-term valve-related survival for stentless aortic root and Toronto SPV bio-prosthesis was as good as that for stented pericardial aortic bio-prostheses. For full-root configuration this survival advantage was statistically significant. There seems to be not one but different ideal biological valve substitutes for different subgroups of patients. In patients with small aortic root or exposed to prosthesis-patient mismatch full-root implantation of stentless bio-prostheses may better meet functional needs of individual patients. Longer follow-ups on newer generation of stented bio-prostheses are needed for comparison of their hemodynamic performance with stentless counterparts especially in full-root configuration.
Keywords: Aortic valve; Stented; Stentless; Substitute.
Similar articles
-
Full-root aortic valve replacement with stentless xenograft achieves superior regression of left ventricular hypertrophy compared to pericardial stented aortic valves.J Cardiothorac Surg. 2015 Feb 3;10:15. doi: 10.1186/s13019-015-0219-8. J Cardiothorac Surg. 2015. PMID: 25643748 Free PMC article.
-
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots.J Vis Exp. 2017 May 21;(123):55632. doi: 10.3791/55632. J Vis Exp. 2017. PMID: 28570525 Free PMC article.
-
Stentless and stented aortic valve replacement in elderly patients: Factors affecting midterm clinical and hemodynamical outcome.Eur J Cardiothorac Surg. 2006 Nov;30(5):706-13. doi: 10.1016/j.ejcts.2006.07.017. Epub 2006 Sep 6. Eur J Cardiothorac Surg. 2006. PMID: 16950630
-
Stentless aortic valve replacement: an update.Vasc Health Risk Manag. 2011;7:345-51. doi: 10.2147/VHRM.S11253. Epub 2011 Jun 2. Vasc Health Risk Manag. 2011. PMID: 21731886 Free PMC article. Review.
-
Stentless valves for aortic valve replacement: where do we stand?Curr Opin Cardiol. 2007 Mar;22(2):96-103. doi: 10.1097/HCO.0b013e328014670a. Curr Opin Cardiol. 2007. PMID: 17284987 Review.
Cited by
-
Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity.Nat Rev Cardiol. 2021 Feb;18(2):92-116. doi: 10.1038/s41569-020-0422-8. Epub 2020 Sep 9. Nat Rev Cardiol. 2021. PMID: 32908285 Review.
-
Prosthesis-patient mismatch in transcatheter and surgical aortic valve replacement.Ann Cardiothorac Surg. 2024 May 31;13(3):211-223. doi: 10.21037/acs-2023-aae-0166. Epub 2024 Apr 28. Ann Cardiothorac Surg. 2024. PMID: 38841078 Free PMC article. Review.
-
Individualized Selection of Valve Intervention Strategies in Aortic Disease Is Key for Better Outcomes.J Pers Med. 2025 Aug 1;15(8):337. doi: 10.3390/jpm15080337. J Pers Med. 2025. PMID: 40863399 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical